Patient Perspectives on Living With Severe Prurigo Nodularis

Because of a paucity of qualitative research on prurigo nodularis (PN), the symptoms and impacts of PN that are most important to patients are poorly understood. To explore patients' perspectives on their PN symptoms and to understand the impacts of the condition. One-on-one qualitative telepho...

Full description

Saved in:
Bibliographic Details
Published in:JAMA dermatology (Chicago, Ill.) Vol. 159; no. 11; p. 1205
Main Authors: Rodriguez, Danielle, Kwatra, Shawn G, Dias-Barbosa, Carla, Zeng, Fanyang, Jabbar Lopez, Zarif K, Piketty, Christophe, Puelles, Jorge
Format: Journal Article
Language:English
Published: United States 01-11-2023
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Because of a paucity of qualitative research on prurigo nodularis (PN), the symptoms and impacts of PN that are most important to patients are poorly understood. To explore patients' perspectives on their PN symptoms and to understand the impacts of the condition. One-on-one qualitative telephone interviews were held with English-speaking US adults aged 18 years or older with a confirmed diagnosis of PN, severe pruritus, and moderate to severe sleep disturbance. Participants were recruited via patient associations, patient panels, and social media posts. Interviews took place between September 10, 2020, and March 16, 2021. The main symptoms of PN and their impacts on quality of life were identified by content analysis of deidentified interview transcripts. A total of 21 adults with PN (mean [SD] age, 53.1 [11.8] years; 15 [71%] female; 2 African American or Black patients [10%], 1 Asian patient [5%], and 18 White patients [86%]; of these, 1 patient [ 5%] had Hispanic or Latino ethnicity) participated in the interviews. All participants reported itch, pain associated with PN, bleeding or scabbing, and dry skin. Other frequently reported symptoms included lumps or bumps (95%), having a crust on the skin (95%), burning (90%), stinging (90%), lesions or sores (86%), skin discoloration (86%), and raw skin (81%). Of the 17 participants who indicated what their worst symptoms were, 15 (88%) identified itching as the worst or 1 of the worst symptoms. The most frequently reported impacts of PN for quality of life were changes in sleep (100%), daily life (100%), feelings or mood (95%), relationships (95%), social life (81%), and work or school (71%). Overall, the worst impact of PN was its association with impaired feelings or mood. This qualitative study suggests the importance of itching, sleep disturbance, and other symptoms and impacts of PN. This information can be used to guide end point selection in clinical trials and to inform patient-centric decision-making in clinical practice.
AbstractList Because of a paucity of qualitative research on prurigo nodularis (PN), the symptoms and impacts of PN that are most important to patients are poorly understood. To explore patients' perspectives on their PN symptoms and to understand the impacts of the condition. One-on-one qualitative telephone interviews were held with English-speaking US adults aged 18 years or older with a confirmed diagnosis of PN, severe pruritus, and moderate to severe sleep disturbance. Participants were recruited via patient associations, patient panels, and social media posts. Interviews took place between September 10, 2020, and March 16, 2021. The main symptoms of PN and their impacts on quality of life were identified by content analysis of deidentified interview transcripts. A total of 21 adults with PN (mean [SD] age, 53.1 [11.8] years; 15 [71%] female; 2 African American or Black patients [10%], 1 Asian patient [5%], and 18 White patients [86%]; of these, 1 patient [ 5%] had Hispanic or Latino ethnicity) participated in the interviews. All participants reported itch, pain associated with PN, bleeding or scabbing, and dry skin. Other frequently reported symptoms included lumps or bumps (95%), having a crust on the skin (95%), burning (90%), stinging (90%), lesions or sores (86%), skin discoloration (86%), and raw skin (81%). Of the 17 participants who indicated what their worst symptoms were, 15 (88%) identified itching as the worst or 1 of the worst symptoms. The most frequently reported impacts of PN for quality of life were changes in sleep (100%), daily life (100%), feelings or mood (95%), relationships (95%), social life (81%), and work or school (71%). Overall, the worst impact of PN was its association with impaired feelings or mood. This qualitative study suggests the importance of itching, sleep disturbance, and other symptoms and impacts of PN. This information can be used to guide end point selection in clinical trials and to inform patient-centric decision-making in clinical practice.
Author Puelles, Jorge
Piketty, Christophe
Rodriguez, Danielle
Dias-Barbosa, Carla
Jabbar Lopez, Zarif K
Kwatra, Shawn G
Zeng, Fanyang
Author_xml – sequence: 1
  givenname: Danielle
  surname: Rodriguez
  fullname: Rodriguez, Danielle
  organization: Evidera, Seattle, Washington
– sequence: 2
  givenname: Shawn G
  surname: Kwatra
  fullname: Kwatra, Shawn G
  organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland
– sequence: 3
  givenname: Carla
  surname: Dias-Barbosa
  fullname: Dias-Barbosa, Carla
  organization: Evidera, Ivry-sur-Seine, France
– sequence: 4
  givenname: Fanyang
  surname: Zeng
  fullname: Zeng, Fanyang
  organization: Evidera, Bethesda, Maryland
– sequence: 5
  givenname: Zarif K
  surname: Jabbar Lopez
  fullname: Jabbar Lopez, Zarif K
  organization: Galderma, Zug, Switzerland
– sequence: 6
  givenname: Christophe
  surname: Piketty
  fullname: Piketty, Christophe
  organization: Galderma, Zug, Switzerland
– sequence: 7
  givenname: Jorge
  surname: Puelles
  fullname: Puelles, Jorge
  organization: Galderma, Zug, Switzerland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37728897$$D View this record in MEDLINE/PubMed
BookMark eNo1j9lKw0AYRgdRbK19hTIvkDpbZgFvpLhB0ICKl2WS_FOnZGNmEvDtLajfzbk4cOC7Quf90ANCG0q2lBB6c7SdbSB0Ng3tlhHGt5zl9AwtGZU6k0SLBVrHeCSnaUIEp5dowZViWhu1RLelTR76hEsIcYQ6-RkiHnpc-Nn3B_zp0xd-gxkC4DJMwR8G_DI0U2uDj9fowtk2wvqPK_TxcP--e8qK18fn3V2RWSFZyupKksoJY5QCa6Q0VnCmmpOsHTU5ECOYZk3tpKuMoYpSXQmXm1pz56hkbIU2v91xqjpo9mPwnQ3f-_8b7AcB_U1j
CitedBy_id crossref_primary_10_1111_jdv_20102
crossref_primary_10_1007_s10787_024_01436_9
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1001/jamadermatol.2023.3251
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 2168-6084
ExternalDocumentID 37728897
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0R~
4.4
53G
AAWTL
ABJNI
ACGFS
ADBBV
AENEX
AFOSN
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AMJDE
ANMPU
BCGUY
BRYMA
C45
CGR
CUY
CVF
EBD
EBS
ECM
EIF
EMOBN
EX3
NPM
OB3
OBH
OGROG
OHH
OVD
PQQKQ
RAJ
SV3
TEORI
WOW
ID FETCH-LOGICAL-a462t-cb60bf49977ea9669a4327da46cf195e094282dcf6fb9917118b4f59c83ff1622
IngestDate Sat Nov 02 12:21:28 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a462t-cb60bf49977ea9669a4327da46cf195e094282dcf6fb9917118b4f59c83ff1622
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC10512162
PMID 37728897
ParticipantIDs pubmed_primary_37728897
PublicationCentury 2000
PublicationDate 2023-11-01
PublicationDateYYYYMMDD 2023-11-01
PublicationDate_xml – month: 11
  year: 2023
  text: 2023-11-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JAMA dermatology (Chicago, Ill.)
PublicationTitleAlternate JAMA Dermatol
PublicationYear 2023
SSID ssj0000800431
Score 2.4843311
Snippet Because of a paucity of qualitative research on prurigo nodularis (PN), the symptoms and impacts of PN that are most important to patients are poorly...
SourceID pubmed
SourceType Index Database
StartPage 1205
SubjectTerms Adult
Ethnicity
Female
Humans
Male
Middle Aged
Pain
Prurigo - diagnosis
Prurigo - drug therapy
Pruritus - drug therapy
Quality of Life
Skin
Title Patient Perspectives on Living With Severe Prurigo Nodularis
URI https://www.ncbi.nlm.nih.gov/pubmed/37728897
Volume 159
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LSwMxEA6tQvEivt-Sg7eyZZNssyl4EW0RtCI-ULxIdjeBQt0V2-Lfd_LYbbUoevASygbSZufrZL7JPBA66sARSxIeBVnSjoMoFWEgtYKBUBpqTVliS2yc38ZXj-KsG3VrtbK12vTZv0oanoGsTebsH6RdLQoP4DPIHEaQOoy_kvu1K5RqQ9t9FqW9EbgcWNfBg_G73irYlmpev02AmxfNqyIzwaiD0SdLFbRxMzN6e-zKNJnrXhe3YfXKcNia8SLcFBksNXHuaJe2Pqwgc_Eux7adkSkP_Z5P23mdDeQoMDcexUj66JNhdUw8KaeGeqCupD9fvXuCMp-nZ08Xq8Yo4SLgoWsEV-lcXwbcg4vMqFBCbR72vG6f9hQoN98yX9hi1JWsnRHu64uVLgPqIISL__159kvN7XKqjupgQRkj-7Rfee6MjQ1mV5lu7ktYzf-mJdQo1_nCWaztcreClj3pwCcOLauopvI11Oj7sIp1dOxBg2dBg4scO9BgAxrsQIM9aHAFmg103-venZ4Hvq1GICNOx0Ga8DDRwHTjWElgux0ZMRpnMJlq0mkrIPzAw7NUc50Ae4iBgiaRbndSwbQmnNJNtJAXudpGWKdcRBFLGEnBjtVaxIJolUkWpqHiku2gLbfv51dXO-W5fCO7387soaUpjvbRooY_pjpA9VE2ObSC-AD6bVd6
link.rule.ids 782
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Patient+Perspectives+on+Living+With+Severe+Prurigo+Nodularis&rft.jtitle=JAMA+dermatology+%28Chicago%2C+Ill.%29&rft.au=Rodriguez%2C+Danielle&rft.au=Kwatra%2C+Shawn+G&rft.au=Dias-Barbosa%2C+Carla&rft.au=Zeng%2C+Fanyang&rft.date=2023-11-01&rft.eissn=2168-6084&rft.volume=159&rft.issue=11&rft.spage=1205&rft_id=info:doi/10.1001%2Fjamadermatol.2023.3251&rft_id=info%3Apmid%2F37728897&rft_id=info%3Apmid%2F37728897&rft.externalDocID=37728897